4D Molecular Therapeutics (FDMT) Shares Outstanding (2019 - 2026)

4D Molecular Therapeutics (FDMT) has 8 years of Shares Outstanding data on file, last reported at $52.3 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $52.3 million, up 12.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $52.3 million (up 12.84% YoY), and the FY2025 annual result was $57.6 million, up 25.8% from the prior year.
• Shares Outstanding declined to $52.3 million in Q1 2026 per FDMT's latest filing, from $57.6 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $57.6 million in Q4 2025 and troughed at $32.3 million in Q1 2022.
• A 5-year average of $43.6 million and a median of $45.8 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding jumped 53.92% in 2024, then retreated 10.05% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $32.6 million in 2022, then surged by 32.02% to $43.1 million in 2023, then climbed by 6.31% to $45.8 million in 2024, then gained by 25.8% to $57.6 million in 2025, then declined by 9.26% to $52.3 million in 2026.
• Business Quant data shows FDMT's Shares Outstanding at $52.3 million in Q1 2026, $57.6 million in Q4 2025, and $46.8 million in Q3 2025.